Can an app beat fatigue in scleroderma? small study tests feasibility

NCT ID NCT07402863

Completed Symptom relief Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a smartphone app called RENEW designed to help people with scleroderma manage fatigue and build resilience. Over 12 weeks, 43 participants used the app to set and track weekly healthy goals. The main goal was to see if people would actually use the app and complete the study, not to measure health improvements.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RENEW app (self-guided resilience-building energy management program)
What this could lead to: If successful, this app could offer a simple, at-home way for people with scleroderma to manage fatigue and improve their quality of life.
What could go wrong: This is a very small, early feasibility study with only 43 participants. It focuses on whether people will use the app, not on whether it actually reduces fatigue. Results may not apply to everyone with scleroderma.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systemic sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC SCLEROSIS

Contacts and locations

Locations

University of Michigan

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.